Parkinson's disease associated with myasthenia gravis. A report of 4 cases.
Levin
Netta
N
Karussis
Dimitrios
D
Abramsky
Oded
O
D000368:Aged; D001379:Azathioprine / Q000627:therapeutic use; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D010300:Parkinson Disease / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D015995:Prevalence; D011729:Pyridostigmine Bromide / Q000627:therapeutic use; D011950:Receptors, Cholinergic / Q000276:immunology
D002800:Cholinesterase Inhibitors; D007166:Immunosuppressive Agents; D011950:Receptors, Cholinergic; D011729:Pyridostigmine Bromide; D001379:Azathioprine